|
⚲
|
| Keyboard |
| Watkins Tim
✚
|
|
|---|---|
| CIK # | 0002065965 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002065965] | |
| 4 | [0002065965] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Watkins Tim | |
| Contineum Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Contineum Therapeutics Inc CTNM
Stock Option (right to buy) · derivative
|
2026-03-02 | Option exercise | 3,611 | $0.00 | |
|
Contineum Therapeutics Inc CTNM
Class A Common Stock
|
2026-03-02 | Sell | 3,611 | $15.02 | 54,237 |
|
Contineum Therapeutics Inc CTNM
Class A Common Stock
|
2026-03-02 | Option exercise | 3,611 | $4.50 | 16,250 |
|
Contineum Therapeutics Inc CTNM
Stock Option (right to buy) · derivative
|
2026-01-30 | Grant | 160,000 | $0.00 | |
|
Contineum Therapeutics Inc CTNM
Class A Common Stock
|
2026-01-28 | Option exercise | 3,611 | $4.50 | 16,250 |
|
Contineum Therapeutics Inc CTNM
Class A Common Stock
|
2026-01-28 | Sell | 2,800 | $14.09 | 39,452 |
|
Contineum Therapeutics Inc CTNM
Class A Common Stock
|
2026-01-28 | Sell | 811 | $14.48 | 11,743 |
|
Contineum Therapeutics Inc CTNM
Stock Option (right to buy) · derivative
|
2026-01-28 | Option exercise | 3,611 | $0.00 | |
|
Contineum Therapeutics Inc CTNM
Stock Option (right to buy) · derivative
|
2025-12-29 | Option exercise | 3,611 | $0.00 | |
|
Contineum Therapeutics Inc CTNM
Class A Common Stock
|
2025-12-29 | Option exercise | 3,611 | $4.50 | 16,250 |
|
Contineum Therapeutics Inc CTNM
Class A Common Stock
|
2025-12-29 | Sell | 3,611 | $12.06 | 43,549 |
|
Contineum Therapeutics Inc CTNM
Stock Option (right to buy) · derivative
|
2025-04-28 | Grant | 260,000 | $0.00 | |
|
Contineum Therapeutics Inc CTNM
Stock Option (right to buy) · derivative
|
2025-04-28 | Grant | 26,000 | $0.00 |